Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

5.45
Delayed Data
As of Dec 09
 0.00 / 0.00%
Today’s Change
4.30
Today|||52-Week Range
11.96
-47.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues7.6M10.5M11.6M11.6M
 
 
 
 
 
Cost of Goods Sold4.1M5.9M6.0M5.2M
 
 
 
 
 
Depreciation And Amortization409.0K489.0K477.0K469.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.0M4.1M5.1M5.9M
 
 
 
 
 
General Expenses5.2M5.9M7.4M5.7M
 
 
 
 
 
Research And Development1.8M2.1M3.8M2.3M
 
 
 
 
 
Total Operating Expenses9.8M12.2M13.9M11.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-1.7M-2.3M177.0K
 
 
 
 
 
Interest Expense On Debt25.0K26.0K24.0K24.0K
 
 
 
 
 
Other Expenses166.0K125.0K81.0K90.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.1M-1.6M-2.2M243.0K
 
 
 
 
 
Income Taxes-6.0K-4.0K-48.0K-5.0K
 
 
 
 
 
Preferred Dividend-7.0K-7.0K-7.0K-7.0K
 
 
 
 
 
Net Income-2.1M-1.6M-2.3M248.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.8M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.8M10.8M10.8M11.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.15-$0.21$0.02
 
 
 
 
 
EPS Diluted-$0.19-$0.15-$0.21$0.02